Soleno Therapeutics (SLNO) Free Cash Flow (2016 - 2026)
Soleno Therapeutics (SLNO) free cash flow from Mar 31, 2016 to Mar 31, 2026. The TTM Soleno Therapeutics (SLNO) free cash flow is $105M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Annual Free Cash Flow change of Soleno Therapeutics (SLNO)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $26M | -44.49% |
| 2025 | $47M | -167.41% |
| 2024 | -$69M | +177.95% |
| 2023 | -$25M | +19.96% |
| 2022 | -$21M | -25.19% |
| 2021 | -$28M | +10.15% |
| 2020 | -$25M | +45.08% |
| 2019 | -$17M | +48.76% |
| 2018 | -$12M | +17.49% |
| 2017 | -$9.95M | -26.51% |
| 2016 | -$14M | +30.69% |
| 2015 | -$10M | N/A |